2 results
Approved WMORecruiting
To evaluate the effectiveness of blood pressure (BP) home monitoring on the occurrence of hypertension, efficacy of BP treatment, QOL, health-related symptoms, work ability and life-style behaviour in women 40-60 yrs, after a previous PE in…
Approved WMOCompleted
To provide idelalisib, a marketed PI3K* inhibitor, in lieu of GS-9820, an investigational second generation PI3K* inhibitor, to subjects receiving GS-9820 in Study GS-US-315-0102 at the time of study closure.